Healthy-looking, defolliculated stage V-VI Xenopus laevis oocytes (EcoCyte Bioscience) were injected with cRNA for GluN1 and GluN2 in a 1:2 ratio (5–10 ng total in 20–50 nl water). Experiments utilized human GluN1/GluN2A and GluN1/GluN2B, rat GluN1/GluN2AC1/GluN2AC2 [33], and rat GluN1/GluN2C and GluN1/GluN2D cRNA. Following injection, oocytes were maintained at 15°C in Barth’s culture medium containing (in mM) 88 NaCl, 2.4 NaHCO3, 1 KCl, 0.33 Ca(NO3)2, 0.41 CaCl2, 0.82 MgSO4, 5 Tris-HCl (pH 7.4 with NaOH), 1 U/mL penicillin, 0.1 mg/mL gentamicin sulfate, and 1 μg/mL streptomycin. Recordings were performed 2–7 days after injection at 23°C. Oocytes were transferred to a recording chamber and continuously perfused with extracellular recording solution containing (in mM) 90 NaCl, 1 KCl, 10 HEPES, 0.5–1 BaCl2, 0.01 EDTA and brought to pH 7.4 with NaOH. Microelectrodes were fabricated from borosilicate glass (World Precision Instruments catalog no. TW150F-4; Sarasota, FL, USA) and voltage clamp and current monitoring were achieved with a two-electrode voltage clamp amplifier (Warner Instruments model OC-725C; Hamden, CT, USA). Currents were low-pass filtered at 10 Hz and digitized at 20 Hz using custom acquisition software written in LabWindows/CVI (National Instruments, Austin, TX, USA), which also controlled solution exchange. Oocytes were held at -40 mV unless otherwise stated. The NMDAR open probability was estimated as previously described using MTSEA to lock open NMDA receptors expressing mutant GluN1(A652C)[62]. Open probability was calculated as (γMTSEA/γCONTROL)/potentiation where γMTSEA and γCONTROL are chord conductances estimated from control and MTSEA-modified GluN1/GluN2A receptors [62] and potentiation is the ratio of current observed after MTSEA modification to control.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.